ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,935Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 651

$419K Total Retail Price of All Prescriptions

Rank: 86 out of 651

558 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Maryland
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 377 349 102 1 4
LEVOTHYROXINE SODIUM 286 263 70 2 3
ATORVASTATIN CALCIUM 269 249 68 3 5
AMLODIPINE BESYLATE 251 225 64 4 2
LISINOPRIL 232 227* 74 5 1
PRAVASTATIN SODIUM 172 155 57 6 11
FUROSEMIDE 159 135 46 7 7
GLIMEPIRIDE 153 140 35 8 39
METFORMIN HCL 147 127 47 9 6
HYDROCHLOROTHIAZIDE 146 141* 44 10 9
METOPROLOL SUCCINATE 140 126 43 11 12
METOPROLOL TARTRATE 138 125 40 12 10
ATENOLOL 124 119* 35 13 13
POTASSIUM CHLORIDE 99 94* 25 14 25
TRAMADOL HCL 95 90* 37 15 14
ESCITALOPRAM OXALATE 87 75 26 16 42
PANTOPRAZOLE SODIUM 84 70 22 17 18
WARFARIN SODIUM 80 75* 30 18 16
LOSARTAN POTASSIUM 77 64 28 19 15
CITALOPRAM HBR 71 66* 20 20 28
CLOPIDOGREL 66 66 18 21 19
METFORMIN HCL ER 66 51 15 21 54
ALPRAZOLAM 66 61* 22 B 21 23
CRESTOR 66 61* 23 21 32
TAMSULOSIN HCL 64 59* 19 25 30
CARVEDILOL 63 58* 19 26 35
OMEPRAZOLE 63 58* 24 26 8
FENOFIBRATE* 57 52* 14 28 72
RAMIPRIL 55 50* 11 29 80
SERTRALINE HCL 55 <11 <11 29 20
ZOLPIDEM TARTRATE 54 35 14 31 26
LORAZEPAM 54 54 14 B 31 27
HYDRALAZINE HCL 52 47* 16 33 61
PROAIR HFA 51 33 24 34 41
IBUPROFEN 50 45* 21 35 65
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.